NVST

Envista Holdings Corporation Common Stock

Congress Trades

Actor	Trade Size	Last Transaction	Amount Range	Price	Current Price
Pete SessionsRepublican $8.0k433.9 shares OtherJun 6, 2024 $1k-$15k $18.44 $23.31

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Keel Paul ADirector, Officer: Chief Executive Officer --12.8k shares Grant / ExerciseMay 25, 2026 $300.2K12.8k shares $23.43 $23.31
Carruthers WendyDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.31
Carruthers WendyDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.31
Gallahue KieranDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.31
Gallahue KieranDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.31
Huennekens R ScottDirector --12.6k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable12.6k shares -- $23.31

News

zacks.comHere's Why You Should Retain NVST Stock in Your Portfolio for Nowzacks.comJun 8

zacks.comWhy Is Envista (NVST) Down 5.9% Since Last Earnings Report?zacks.comJun 5

zacks.comIs NVST Attractive at 15.1x Forward Earnings?zacks.comJun 4

zacks.comNVST Stock Explained for 2026 Growth Drivers and Riskszacks.comJun 3

zacks.comHere's Why Envista (NVST) is a Strong Value Stockzacks.comJun 2

Trade NVST

About Envista Holdings Corp

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

CEO: Paul A. Keel
IPO Date: Sep 18, 2019

Market Data

Open: $23.73
High: $25.03
Low: $23.69
Volume: 2.5M
52W High: $30.42
52W Low: $18.25

Valuation

Market Cap: $4.0B
Enterprise Value: $4.5B

Financials

Free Cash Flow: $230M
Revenue: $2.7B
Net Income: $47M
Cash: $1.2B
Debt: $1.7B

Events

EarningsAug 5

EPS est. 0.33